Future of Oxford lactation research centre secured with £9.12 million donation
24 July 2024
Official Press release: A £9.12 million gift from the Family Larsson-Rosenquist Foundation has endowed an Oxford University research centre investigating the role of hormones in human milk production.
Oxford researcher to lead one of UKRI's new research networks to tackle antimicrobial resistance
23 July 2024
Awards and Appointments Partnerships
Eight new networks, combining different research specialisms, will work together to tackle one of humanity’s biggest threats, antimicrobial resistance (AMR).
Shorter life expectancy during COVID-19 for India’s marginalised
23 July 2024
A new paper published in Science Advances finds that life expectancy in India was 2.6 years lower in 2020 than 2019, with women and marginalised social groups suffering the greatest declines.
Apollo Therapeutics and Oxford University enter into drug discovery and development collaboration
22 July 2024
The University of Oxford and Apollo Therapeutics, a portfolio biopharmaceutical company, announce the signing of a drug discovery and development collaboration aimed at translating breakthroughs made by biomedical researchers at Oxford.
Centre to address global epilepsy challenges launched at Oxford’s Wolfson College
22 July 2024
The University of Oxford is launching The Centre for Global Epilepsy to address the global burden of epilepsy, particularly in lower-income countries.
PSI Director comments on first UK Covid-19 Inquiry report
18 July 2024
Professor Sir Peter Horby responds to the UK Covid-19 Inquiry's Module 1 report published today, which focuses on the UK's pandemic resilience and preparedness.
Côte d’Ivoire makes history as first nation to deploy R21/Matrix-M™ Malaria Vaccine
15 July 2024
Today marks the official rollout of the new R21/Matrix-M™ malaria vaccine - co-developed by the University of Oxford and Serum Institute of India, leveraging Novavax’s Matrix-M™ adjuvant technology. In a historic step in the battle to beat malaria, the first official vaccination is due to take place in Abidjan, Côte d’Ivoire, this morning and will be subsequently rolled-out in 38 districts across the country.
Oxford scientists launch first-in-human vaccine trial for deadly Marburg virus
12 July 2024
Scientists at the University of Oxford have launched a new clinical trial to test a vaccine to protect people against deadly Marburg virus.
Science Together celebrates a third year of community-led research collaborations
8 July 2024
Science Together hosts a Summer Celebration to recognise the seven community-led research collaborations formed over the last ten months through the Science Together engagement with research programme.
New AI-led science initiative will help protect communities hit by climate change in East Africa
4 July 2024
The United Nations World Food Programme (WFP), Oxford University Physics Department, IGAD Climate Prediction and Applications Centre (ICPAC), and various national forecasting and meteorology agencies across east Africa are joining forces to pioneer a transformative initiative that is revolutionising extreme weather forecasting and early warning systems in the region.
KEMRI Wellcome Trust Research Programme (KWTRP) Annual Policy Engagement Forum
4 July 2024
The KEMRI Wellcome Trust Research Programme (KWTRP) hosted its annual policy engagement forum in Nairobi. This year’s forum provided a valuable platform for deliberation between policy stakeholders and researchers, focusing on their research needs and policy priorities.
Major UK Study Reveals Shifting Trends and Persistent Challenges in Heart Disease Over the Last 20 Years
27 June 2024
A groundbreaking new study has shed light on how the landscape of heart disease has evolved in the UK over the past two decades. Researchers analyzed electronic health records from the Clinical Practice Research Datalink (CPRD GOLD and Aurum), encompassing a representative cohort of 22 million individuals. This included 1,650,052 people newly diagnosed with at least one cardiovascular disease (CVD) between 2000 and 2019, with an average age of 70.5 years, of whom 48% were women.
OpenSAFELY provides vital real-time data to support NHS ambition for safer opioid use
27 June 2024
Amid concerns that the COVID-19 pandemic might have led to increases in opioid prescribing, a new study from researchers at the Bennett Institute for Applied Data Science, University of Oxford, demonstrates how the OpenSAFELY database can be used to conduct detailed analyses of opioid prescribing practices, in line with key recommendations from recent NHS England guidance aimed at preventing and reducing opioid harm.
Department's Centre for Research Equity launches historic partnership to advance health equity in Northern Ireland
26 June 2024
Department's Centre for Research Equity partners with Northern Ireland to advance health equity. This groundbreaking collaboration aims to improve health outcomes, reduce disparities, and ensure research benefits all communities through inclusive, community-driven approaches.
First UK trial of Deep Brain Stimulation for children with epilepsy begins
26 June 2024
A teenager who is the first patient to take part in a UK clinical trial to use deep brain stimulation to treat epilepsy has seen his daytime seizures reduce by 80%.
Cholesterol-lowering drug slows progression of eye disease in people with diabetes
24 June 2024
The LENS trial has demonstrated that fenofibrate, a drug usually used to lower cholesterol, reduces the risk of progression of diabetic retinopathy by 27%. The results were announced today at the American Diabetes Association Scientific Sessions and published in NEJM Evidence.
Cross-species immune responses could lead to innovative treatments
24 June 2024
A new study published by Oxford researchers as part of an international collaboration in the Journal of Biological Chemistry has found that an important section of our immune system, that involves the molecule MR1 and MAIT cells, is evolutionarily conserved in multiple species.
Sepsis patients could get the right treatment faster based on their genes
21 June 2024
Sepsis patients could be treated based on their immune system’s response to infection, not their symptoms. New research uncovers how different people respond to sepsis based on their genetic makeup, which could help identify who would benefit from certain treatments and lead to the development of targeted therapies.
Novel data method sheds light on hidden patterns of kidney inflammation
20 June 2024
Globally kidney disease is forecast to be the 5th leading cause of death by 2040, and in the UK more than 3 million people are living with the most severe stages of chronic kidney disease. Chronic kidney disease is often due to autoimmune damage to the filtration units of the kidney, known as the glomeruli, which can occur in lupus, a disease which disproportionally affects women and people of non-white ethnicities, groups often underrepresented in research. Treatment options are limited, can have life threatening side-effects and often don’t slow the disease, which can then progress to end stage, requiring dialysis or a kidney transplant.
OUCRU Hosts “Agent-based Modelling (ABM) with GAMA” Course: Potential Application in Health Sciences
18 June 2024
In June 2024, OUCRU organised a training course "Agent-based Modelling (ABM) with GAMA" in Ho Chi Minh City. Participants from multiple countries explored the practical application of ABM in health science through theoretical lectures, practical sections, and collaborative group projects.